everyone. remember and the Zack being morning quarter. performance delivered you, that can strong FMC good we most in operating the challenging one environments of financial Despite Thank
strong by XX%, set importantly, basis America EBITDA year. quarter America a to we by we by period, earlier And EPS in up margins by taking and growth cost to price. sales only year significantly QX, continued QX actions very approximately EBITDA with in regaining the XX%, disruptions, above-market our be our headwinds. Latin the and deliberate by confronting revenue XXX points, from and pressures, In previously the As North and expanded XX%. indicated, contributed quarter. currency our driving growth emerging but while Not grew supply volume lost also prior
all strong cost gains regions. New labor availability, games. in expanded for some are in product increasing for headwinds costs, and launches faced and pricing continued again to we created a currency on the Acreage researching strong of in logistics the freight, price increases and raw and inflation, inconsistent key Building in lead-times contributed XXXX. input Rising expansion a combination sentiment we to increase ag profitability commodity platform in to year the expect volume of robust ocean growth backdrop market, biologicals XXXX quarter. are long the prepared positive geographies across through we and this of our growth soft prices drive positive challenges them expenses, material navigate key the
of This to share in than $XXX as and was of was which Adjusted both driven gain and diluted EBITDA EBITDA by gains earnings XX% prior grew in The organic all pricing Indonesia. on and in quarter driven year were our was US, by the growth $X.XX steep XX% Company in an and cost Germany, in increase points all especially North Adjusted product the headwinds Russia, million led broad-based the Growth in the per also tax quarter, $X.XX inflation. India, This basis QX We an basis strong across approximately company all the slide expansion regions, on by results billion America. business year-over-year fourth repurchases plant the contributed projected XX% rate versus as America XX% Australia, well Brazil, XX%. France, categories from was Argentina, insecticides in by lower Latin results. more across strong a revenue while of Mexico, increase pricing volume herbicides, revenue QX despite an health improvement as to were EBITDA, three. increase primarily increase was regions compared to gains and XXXX. up year-over-year Turning XX.X%, reported margin margins XXX well as gains reported period. quarter than a a driven growth. double-digit share mix reflects increase
in now product launches the expansion prior record prices, year period, and fourth higher slide versus of posted and X. selective XX% America an Moving growth grew over by the in all-time new for for driven region revenue herbicides, quarter Cyazypyr. Adjusting quarter with Rynaxypyr to North region continued lost of strength XXXX. the sales market XX% still the
grew business were XX% US last the more in portfolio Growth sales its especially, Argentina launched great conditions of several corn. crops, performance control. Mexico. region Our quarter Hero revitalizing with the in experienced volume stint driven and and Insecticides crops price business coming was these and increases. years. market in Revenue Brazil cotton year-over-year strong the five acreage by has by increased soy, led We in key our increasing Latin with from than America and driven in for Talisman progress in made mod by XX% for robust Brazil, products that
very compared Agronomic than to in remain EMEA, EMEA potatoes and quarter based EMEA well driven to Vantacor and America, control mainly Asia, herbicides, each grew year-over-year the plant X% diamides coffee by applications more by primarily quarter for on organically rice and for season by sales momentum weather key a use Overwatch the and than price the herbicides partially health quarter of euro. down of fruit and growth strong notably In XXXX cereals, the launches applications. continued in offset country fungicides our diamides, and the was sugarcane X% at diamide the brands number or and positive from year-over-year X% finally good corn demand a in driven strong vegetables. sales of diamide as our north. shift cotton pillar such based start XX% Overall, in weakening for our in due our business of fourth diamide well Asia. increases the cropping least for decreased And as in quarter. the volumes We Latin Growth in portfolio a in Australia most also pulses revenue as Asia including X% to and In crops business due the by insect of the demand global in driven rice partner grew conditions fruits on as greater Rynaxypyr summer in South Isoflex active. on for in more to XX% driven and herbicide growth beet. and the countries sugar delivered to of was saw our resulted our grew India branded and specialty Herbicide Coragen revenue in top our the challenges as and by China. XX%
increases X. and fourth regions. XX% in to Turning EBITDA the in quarter up all was driven slide price by volume
volume benefit The in soy insecticide in pricing American and and for Mexico and FMC's fruit applications me driver, includes single-digit Let $XXX pricing and biggest from and by sales that Latin definition financial Brazil. up all were the mix corn selective new was mid the launches. $XX the quantity of you regions. million the US with growth, quarter countries improvement herbicides for in million in with from in the driven gains vegetables is up remind Volume insecticides Price increases. US actions
expect remain in material, $XXX we FX other similar primarily million quarter pricing We in in Raw Latin negative cost a elevated the headwinds. to seasons. America. packaging new geographies logistics million factor the in contributing costs was $XX the and actions approach as
year basis compared cost results organic Adjusted X% and over headwinds. $XXX in $XXX last a slide $X.XXX on from Moving to on Approximately, reported of billion X% even reflects increase in growth. billion an EBITDA sales was XXXX X. a million the to in launched We X% with five reported revenue, in full increase products which came $X.XX million years.
per We deliver a to continue share an This the D&A. XXXX $X.XX count EBITDA of as adjusted share by lower higher diluted EBITDA rate increase increase XX% and industry-leading versus XXXX. was increase well earnings improved offset lower margins primarily tax of XX.X%. by interest expense, partially as driven was
an all-time Health of conversion excellent period. for his cash number an As I delivered we growth mentioned And XX% have Andrew over XXXX million a our will remarks of cash $XXX Plant was XX% flow in the business year also of in of of increase prior year the detail our the record. record times.
and quickly outlook, details on biologicals earnings before platform. this includes So FMC's which let to XXXX moving QX me share on business more
used slide and Innovation in peptides early for Denmark tenant market commercialize with technologies Latin a We R&D Bio-Thera with most model world. with MicroPet a in integrated with alternatives. providing with headquarters throughout In and XXXX and protection to Asia to pheromones technologies. nutrition profiles the technologies compared approximately seed biologicals' can to and Health treatment five of evolving commitment demonstrated today for have entered improving is at to X. center utilize access We've through biological world, commercial business Health nutrient actively portfolio pressures making business, Novozymes Christian or and and challenges, reset resistance the growth downstream Plant generally into entered At that when market a an Moving All X/X in emerging FMC America Regulatory improve approximately make to collaboration the business of also more in established well same time, business. biologicals. These the million specialized of Health Health as Hansen. while favorable Plant recently yields. our years. and our crop and double-digit regions crop FMC disease enzyme-based with as alliance the made $XXX at we space characteristics We these up management the business uptake, to a of our growth crop strategic the of X.Xx food FMC's with the FMC's and Copenhagen Ventures. dedicated synthetic last such Center margin consists residue XXXX, products. Biologicals chain synthetic accretive are manufacturers some Health for requirements factors four part Plant insect European protection develop growing revenue and investments leverages the reduced Plant be current environmental control, small as FMC's biologicals an contract over protection integral sustainable around innovation. driving Planet organization market has a the acquisition and
health Our million goal by plant $XXX business strategic sales external internal targeting by as well in driven as partnerships, XXXX, our of M&A. is a pipeline, a
X Slide outlook. and to Moving growth FMC's
X% projecting four as and line all are with biological leveraging gains across synthetic price increases. the growth of in XXXX our top full We as well breadth portfolios regions,
in with as well increase as XX% New XXXX in is This from anticipated last approximately more versus years. the the represent accelerate of $XXX our launched a XXXX. product total XX% five growth from than in category to million coming sales, products would sales projected
opportunities range we supportive of the growth Diamides, America, our of across well in-season herbicides in and biologicals. Latin Our of by as underrepresented. drive an Colombia, anticipate and sugarcane, soy, selective countries the launched as new for other offset are insecticides, for expect and Latin including and crops a registrations. plant other as corn health and pests to targeting range of cost whole increases expansion crops. American corn, business specialty due crops and Significant in insect in momentum to price soy, grow which expected recently region Peru, remain cotton, the will control Paraguay to In We Vantacor well Zawar headwinds. pricing North including American double key exist market announced products remain help growth products Biologicals corn cotton. acreage We fungicide as such in as US a we driven currently still to expect digit
and particularly product these a specialty FX for line key lever is suitable in Our the Pricing cost in region headwinds. will Diamide countries. offset to be crops help
innovative launching is year. soy We based peanut fungicide and our this targeting an crops. Fluindapyr in fungicide also in spectrum Argentina Paraguay on are Onsuva Onsuva diseases and broad active
biologicals. is will Diamides Overwatch including Our rice for broader India for business to countries across weeds continue be Asia registrations Diamides and which products. market driven an new portfolio, and several sugarcane, to specialty plant such by herbicide to its double-digit health expected recent especially products select expected growth with our and on is Asia our trajectory and and well grow important new crops as as Australia pulses. in as growth continue targets the in launches cereals drive annual broadleaf canola ryegrass will
We Vietnam expect India, and be Indonesia, important to in and Pakistan. market the FX especially And continue countries Malaysia. such expanding watch to as access India in will volatility Philippines,
health trajectory. will are growth Finally, cotton Spain, XRL other The and such corn. desiccation growth expected and the UK projecting Cyazypyr region products countries. growing in potatoes volume as EMEA are Benevia, region. used will continue is for and plant maintain Spotlights African Middle the grow Herbicides Berrima and countries East by Coragen to and on and top Plus vegetables, across in brands projected their business UK olives such the which the and Germany, led grow also volumes as the citrus. in other to fruit, Mexico brands Biologicals and including is
new wheat to volatility terms control is a the new region. in barley introducing Turkish magnitude herbicide in Lira and And to other of of Registration the years. the against a are weed a the dollar. currencies previous projected Euro, be countries In we US grass with headwind launches, for headwind be losses similar weakening FX and will in
and high Turning with to across continue sold, to goods are costs well respect Logistics input transportation availability. tight. inflationary air FMC's costs nine the levels. as ocean, by pressures, of of to outlook. costs driven tight remain as at remain and Packaging and ground cost elevated we our see lack Higher also With elevated chain. the supply costs availability remains slide cost
XXXX. are price seeing However, we alleviation. chain-related expect initial Overall, signs through to supply of we persist challenges
anticipated through pipelines. the opportunities, visibility the as labor into be with support SG&A products view cost and in for driven half R&D our of year development inflation. to launched access move SG&A R&D have first Increased quarter. continue of spend expansion investments the once by we'll of and we Overall, and advance as managed maintained half clearer be will second We recently activities, ratios to will closely. second are better the grow historical have and in commercial market costs especially well spend and as line we a discovery
slide XX to outlook. our XXXX and full review Turning the financial of year and QX
Adjusted to at the forecasted compared midpoint revenue midpoint. year X% $X.XX range range of representing the billion at EBITDA $X.XX X% growth in billion, is We in to to $X.XX the of expect billion, billion the full to reflecting be XXXX. $X.XX growth year-over-year
diluted any the We assumes expect per the factor year. adjusted share, earnings in benefit count to and This of increase share representing an of million approximately XXX potential midpoint. does $X.XX repurchases in X% of not share at the $X.XX a
to $XXX Adjusted Looking million, X% to $XXX increase period. range the range midpoint representing prior at in revenue the at quarter to quarter, the X% at first be billion the versus the a to million XXXX. year the we first in of be growth $X.XX $X.XX forecasted of midpoint EBITDA to forecast billion, is compared representing
per range to versus We increase XXX count diluted the of share XXXX assuming to $X.XX, million. and earnings the of an expect XX% of representing share in QX a be midpoint $X.XX approximately at adjusted
of Moving could X. drive end I to some potential our either to slide to the range. results guidance want that factors the of highlight
year, input assuming cost costs midpoint mitigated we and calendar would of end to inflation the of any and/or increases of end remain lower in towards internal guidance, variables, price our further trend price be results adjusted outcome. are mid severe and guidance. range. which events also through efficiencies is For easing cannot would mitigated. inflation our our further are single-digit or the high If and would the more EBITDA elevated disruptions the supply high results Alternatively, headwinds influence FX the the Weather drive increases of the towards realizing final becomes
regions increases will to factor revenue across in a and expected EBITDA our and be XXXX, price negative all outlook. volume growth. year to drivers. XX in Turning full FX slide volatility and revenue expansion Again drive is strong
by the guidance headwinds. margin FX incremental and increases, benefits partially of volumes EBITDA and price offset cost Our reflects high
and drivers. Moving to slide XX the QX
On the especially expected line, momentum and volume revenue America America, Latin is to is North in continue, where growth strong.
increases quarter. we've an will price European from the driver announced already the in-season US. noted currencies. FX As regions be important principally in Price all We're in headwinds earlier, for increases anticipating
Regarding EBITDA the chains some ag provide drivers, long supply us visibility in into chem costs. industry,
costs in Overall, as that volumes headwinds to And year-over-year second materials inflationary and that the we as The driven quarter. levels. subsided EBITDA by higher high-margin continue so growing Andrew. the elevated and in at call the far from pressures X% I'll offset quarter, are EBITDA saw the in of increases. have of the price turn half XXXX will well will raw not benefit we forecasting growth now FX partially over remain
